Non-Oncology Precision Medicine Market Size will Reach USD 150.2 Billion by 2030

According to Precedence Research, during the forecast period of 2022 to 2030, the global non-oncology precision medicine market is estimated to develop at a compound annual growth rate (CAGR) of 9.98%. The global non-oncology precision medicine market was valued at USD 63.79 billion in 2021, and it is predicted to exceed USD 150.2 billion by 2030. The study investigates several elements and their consequences on the growth of the non-oncology precision medicine market.

Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/1798

This report focuses on non-oncology precision medicine market volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall non-oncology precision medicine market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Middle East & Africa, Latin America, etc.

The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

In-Depth Analysis on Competitive Landscape

The report sheds light on leading manufacturers of non-oncology precision medicine, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the production of non-oncology precision medicine has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the non-oncology precision medicine market.

Some of the prominent players in the non-oncology precision medicine market include:

• Pfizer Inc.
• Qiagen Inc.
• Quest Diagnostics Inc.
• Medtronic
• Novartis
• Laboratory Corporation of America Holdings
• bioMérieux SA
• Abbott Laboratories
• F. Hoffmann-La Roche A
• Eli Lilly & Company

Ask Here For More Customization Study@ https://www.precedenceresearch.com/checkout/1798

Segments Covered in the Report

By Product Type

• Diagnostics
  • Genetic Tests
  • Biomarker Based Tests
  • Others
• Therapeutics

By Application

• Oncology
• CNS
• Immunology
• Respiratory
• Infectious Diseases
  • Respiratory Infections
  • Gastrointestinal Infections
  • Sexually Transmitted Infections
  • Others
• Neurology
  • Neurodegenerative Disorders
  • Neuropsychiatric Disorders
  • Others
• Cardiovascular
  • Cardiac Myopathies and Arrhythmia
  • Others
• Lifestyle and Endocrinology
• Gastroenterology
• Others

By End-use

• Hospitals
• Diagnostic Centers
• Research & Academic Institutes
• Others

By Ecosystem

• Applied Sciences
  • Genomics
  • By Technology
    • Polymerase Chain Reaction (PCR)
    • Precision Medicine Next-Generation Sequencing (PM NGS)
    • Genome Editing
    • Other Technologies
  • Pharmacogenomics
  • Other Applied Sciences
• Precision Diagnostics
  • Molecular Diagnostics (MDx)
  • Medical Imaging
• Digital Health and Information Technology
  • Clinical Decision Support Systems (CDSS)
  • Big Data Analytics
  • IT Infrastructure
  • Genomics Informatics
  • In-Silico Informatics
  • Mobile Health
• Precision Therapeutics
  • Clinical Trials
  • Cell Therapy
  • Drug Discovery and Research
  • Gene Therapy

Regional Segmentation

• Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
• Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
• North America [United States, Canada, Mexico]
• South America [Brazil, Argentina, Columbia, Chile, Peru]
• Middle East & Africa [GCC, North Africa, South Africa]

Some of the important ones are:

• What can be the best investment choices for venturing into new product and service lines?
• What value propositions should businesses aim at while making new research and development funding?
• Which regulations will be most helpful for stakeholders to boost their supply chain network?
• Which regions might see the demand maturing in certain segments in near future?
• What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
• Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
• Which government regulations might challenge the status of key regional markets?
• How will the emerging political and economic scenario affect opportunities in key growth areas?
• What are some of the value-grab opportunities in various segments?
• What will be the barrier to entry for new players in the market?

Table of Contents

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Non-Oncology Precision Medicine Market 

5.1. COVID-19 Landscape: Non-Oncology Precision Medicine Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Non-Oncology Precision Medicine Market, By Product Type

8.1. Non-Oncology Precision Medicine Market, by Product Type, 2022-2030

8.1.1. Diagnostics

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Therapeutics

8.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Non-Oncology Precision Medicine Market, By Application

9.1. Non-Oncology Precision Medicine Market, by Application e, 2022-2030

9.1.1. Oncology

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. CNS

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Immunology

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Respiratory

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Infectious Diseases

9.1.5.1. Market Revenue and Forecast (2017-2030)

9.1.6. Neurology

9.1.6.1. Market Revenue and Forecast (2017-2030)

9.1.7. Cardiovascular

9.1.7.1. Market Revenue and Forecast (2017-2030)

9.1.8. Lifestyle and Endocrinology

9.1.8.1. Market Revenue and Forecast (2017-2030)

9.1.9. Gastroenterology

9.1.9.1. Market Revenue and Forecast (2017-2030)

9.1.10. Others

9.1.10.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Non-Oncology Precision Medicine Market, By End-use 

10.1. Non-Oncology Precision Medicine Market, by End-use, 2022-2030

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Diagnostic Centers

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Research & Academic Institutes

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Non-Oncology Precision Medicine Market, By Ecosystem 

11.1. Non-Oncology Precision Medicine Market, by Ecosystem, 2022-2030

11.1.1. Applied Sciences

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Precision Diagnostics

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Digital Health and Information Technology

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Precision Therapeutics

11.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Non-Oncology Precision Medicine Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.1.2. Market Revenue and Forecast, by Application (2017-2030)

12.1.3. Market Revenue and Forecast, by End-use (2017-2030)

12.1.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.1.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.1.5.3. Market Revenue and Forecast, by End-use (2017-2030)

12.1.5.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.1.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.1.6.3. Market Revenue and Forecast, by End-use (2017-2030)

12.1.6.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.2.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.3. Market Revenue and Forecast, by End-use (2017-2030)

12.2.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.2.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.5.3. Market Revenue and Forecast, by End-use (2017-2030)

12.2.5.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.2.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.6.3. Market Revenue and Forecast, by End-use (2017-2030)

12.2.6.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.2.7.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.7.3. Market Revenue and Forecast, by End-use (2017-2030)

12.2.7.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.2.8.2. Market Revenue and Forecast, by Application (2017-2030)

12.2.8.3. Market Revenue and Forecast, by End-use (2017-2030)

12.2.8.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.3.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.3. Market Revenue and Forecast, by End-use (2017-2030)

12.3.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.3.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.5.3. Market Revenue and Forecast, by End-use (2017-2030)

12.3.5.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.3.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.6.3. Market Revenue and Forecast, by End-use (2017-2030)

12.3.6.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.3.7.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.7.3. Market Revenue and Forecast, by End-use (2017-2030)

12.3.7.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.3.8.2. Market Revenue and Forecast, by Application (2017-2030)

12.3.8.3. Market Revenue and Forecast, by End-use (2017-2030)

12.3.8.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.4.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.3. Market Revenue and Forecast, by End-use (2017-2030)

12.4.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.4.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.5.3. Market Revenue and Forecast, by End-use (2017-2030)

12.4.5.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.4.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.6.3. Market Revenue and Forecast, by End-use (2017-2030)

12.4.6.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.4.7.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.7.3. Market Revenue and Forecast, by End-use (2017-2030)

12.4.7.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.4.8.2. Market Revenue and Forecast, by Application (2017-2030)

12.4.8.3. Market Revenue and Forecast, by End-use (2017-2030)

12.4.8.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.5.3. Market Revenue and Forecast, by End-use (2017-2030)

12.5.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.5.5.2. Market Revenue and Forecast, by Application (2017-2030)

12.5.5.3. Market Revenue and Forecast, by End-use (2017-2030)

12.5.5.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product Type (2017-2030)

12.5.6.2. Market Revenue and Forecast, by Application (2017-2030)

12.5.6.3. Market Revenue and Forecast, by End-use (2017-2030)

12.5.6.4. Market Revenue and Forecast, by Ecosystem (2017-2030)

Chapter 13. Company Profiles

13.1. Pfizer Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Qiagen Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Quest Diagnostics Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Medtronic

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Novartis

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Laboratory Corporation of America Holdings

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. bioMérieux SA

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Abbott Laboratories

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. F. Hoffmann-La Roche A

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Eli Lilly & Company

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/1798

About Us

Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.

From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.

Contact Us:                  

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com